FDA proposes to ease rules on off-label drug use

02/17/2008 | NYTimes.com

The FDA on Friday recommended new guidelines that would let drug and medical-device makers supply doctors with copies of journal articles on off-label uses of their products. Advocates say the proposal would give physicians access to credible scientific data that could potentially save lives, while critics argue that allowing such a practice could compromise patient safety and result in unreliable research on the benefits of drugs and devices.

View Full Article in:

NYTimes.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY